Sanofi (SNY) Shares Gap Down to $38.41
Sanofi (NYSE:SNY) gapped down before the market opened on Monday . The stock had previously closed at $37.91, but opened at $38.41. Sanofi shares last traded at $39.18, with a volume of 1,306,000 shares traded.
Several brokerages have commented on SNY. TheStreet lowered Sanofi from a “buy” rating to a “hold” rating in a research note on Monday, August 22nd. Berenberg Bank restated a “hold” rating and set a $93.00 price target on shares of Sanofi in a research note on Monday, August 15th. Zacks Investment Research lowered Sanofi from a “hold” rating to a “sell” rating in a research note on Wednesday, August 3rd. Citigroup Inc. restated a “neutral” rating on shares of Sanofi in a research note on Tuesday, June 28th. Finally, Barclays PLC upgraded Sanofi from an “equal weight” rating to an “overweight” rating in a research note on Thursday, May 12th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $60.50.
The company’s 50-day moving average price is $40.45 and its 200 day moving average price is $40.65. The firm has a market capitalization of $100.85 billion and a PE ratio of 21.64.
Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products.